Novo Nordisk A/S (NONOF)

Novo Nordisk Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	261,058	384,855	461,550	304,426	256,201	162,142
Market Cap Growth	-52.61%	-16.62%	51.61%	18.82%	58.01%	18.73%
Enterprise Value	273,492	382,368	458,427	302,773	252,890	158,629
Last Close Price	58.60	84.49	100.43	66.88	54.39	35.13
PE Ratio	14.93	27.45	37.19	38.16	35.07	23.41
PS Ratio	5.32	9.55	13.40	11.97	11.90	7.77
PB Ratio	9.87	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	27.55	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	25.42	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	13.64	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	5.66	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	10.99	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	11.89	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	26.63	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.59	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.62	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.52	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.73	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.20	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.51	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	79.17%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.82%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	42.52%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	54.10%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	6.70%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	3.93%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.75%	1.87%	1.39%	1.33%	1.46%	2.13%
Payout Ratio	45.63%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.57%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	3.32%	2.58%	2.48%	2.67%	3.04%	3.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.